LDL-C reducing agents; what genetic tells us

1 September 2019 (13:27 - 13:45)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Professor Brian A Ference

University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail

To be or not to be…but at which goal?

Professor L. Tokgozoglu (Ankara, TR)

Presentation thumbnail

Combination therapy in CV risk reduction: what are we waiting for in dyslipidaemia management?

Professor P. Steg (Paris, FR)

Presentation thumbnail

Getting to goals cost effectively, how can we make a difference?

Professor E. Stroes (Amsterdam, NL)

Access the full session

Session thumbnail

Hypercholesterolemia management - What will be our options after tomorrow?

The Event

ESC Congress 2019

1 September 2019 13:27 CET

You may be interested in

Congress Session

Pharmacogenetics: a tool to guide clinical decisions

Congress Presentation

Pharmacogenetics for mavacamten treatment individualization in patients with obstructive hypertrophic cardiomyopathy

Congress Presentation

Limited visibility and uptake of the clopidogrel pharmacogenomic guidelines among cardiologists

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources